BR112015029559A2 - partícula similar a vírus, ácido nucleico e métodos para produzir rna de fita dupla e sirna, shrna, sshrna, 1shrna e mirna - Google Patents
partícula similar a vírus, ácido nucleico e métodos para produzir rna de fita dupla e sirna, shrna, sshrna, 1shrna e mirnaInfo
- Publication number
- BR112015029559A2 BR112015029559A2 BR112015029559A BR112015029559A BR112015029559A2 BR 112015029559 A2 BR112015029559 A2 BR 112015029559A2 BR 112015029559 A BR112015029559 A BR 112015029559A BR 112015029559 A BR112015029559 A BR 112015029559A BR 112015029559 A2 BR112015029559 A2 BR 112015029559A2
- Authority
- BR
- Brazil
- Prior art keywords
- virus
- 1shrna
- sshrna
- shrna
- mirna
- Prior art date
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 title abstract 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 title abstract 3
- 108091070501 miRNA Proteins 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 150000007523 nucleic acids Chemical class 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 108091027967 Small hairpin RNA Proteins 0.000 title abstract 2
- 108020004459 Small interfering RNA Proteins 0.000 title abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- -1 sirnas Chemical class 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
- C12N15/8616—Special methods for targeting systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5184—Virus capsids or envelopes enclosing drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00041—Use of virus, viral particle or viral elements as a vector
- C12N2795/00042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18111—Leviviridae
- C12N2795/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18111—Leviviridae
- C12N2795/18123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18111—Leviviridae
- C12N2795/18141—Use of virus, viral particle or viral elements as a vector
- C12N2795/18142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361836833P | 2013-06-19 | 2013-06-19 | |
US201361838736P | 2013-06-24 | 2013-06-24 | |
US201361857965P | 2013-07-24 | 2013-07-24 | |
PCT/US2014/041111 WO2014204667A1 (en) | 2013-06-19 | 2014-06-05 | Compositions and methods using capsids resistant to hydrolases |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015029559A2 true BR112015029559A2 (pt) | 2017-12-12 |
Family
ID=52105110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015029559A BR112015029559A2 (pt) | 2013-06-19 | 2014-06-05 | partícula similar a vírus, ácido nucleico e métodos para produzir rna de fita dupla e sirna, shrna, sshrna, 1shrna e mirna |
Country Status (15)
Country | Link |
---|---|
US (2) | US9822361B2 (pt) |
EP (3) | EP3789017A1 (pt) |
JP (1) | JP6636418B2 (pt) |
AU (1) | AU2014281061B2 (pt) |
BR (1) | BR112015029559A2 (pt) |
CA (1) | CA2912131C (pt) |
CY (1) | CY1124583T1 (pt) |
DK (1) | DK3222274T3 (pt) |
ES (1) | ES2847151T3 (pt) |
HU (1) | HUE053033T2 (pt) |
IL (1) | IL242487B (pt) |
MX (2) | MX364809B (pt) |
PL (1) | PL3222274T3 (pt) |
SG (2) | SG11201510181YA (pt) |
WO (1) | WO2014204667A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR089440A1 (es) * | 2011-12-21 | 2014-08-20 | Apse Llc | Procesos que emplean particulas similares a virus (psv) con capsides resistentes a hidrolasas |
HUE053033T2 (hu) | 2013-06-19 | 2021-06-28 | Apse Llc | Hidrolázoknak ellenálló kapszidokat alkalmazó készítmények és eljárások |
US9932563B2 (en) * | 2013-09-11 | 2018-04-03 | Georgia Tech Research Corporation | Compositions and methods for inhibiting gene expressions |
EP3294276A4 (en) * | 2015-05-12 | 2018-10-31 | Apse, Llc | In vivo production of long double stranded rna utilizing vlps |
EP3356531A4 (en) * | 2015-10-01 | 2019-05-29 | Apse Llc | METHODS AND COMPOSITIONS COMPRISING APSE NODES |
JP7140386B2 (ja) * | 2016-03-15 | 2022-09-21 | アプス, インコーポレイテッド | 増加した二本鎖rna産生のための方法及び組成物 |
US10131911B2 (en) | 2016-11-07 | 2018-11-20 | nanoSUR LLC | Post-transcriptionally chemically modified double strand RNAs |
WO2020254876A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Virus-like particle delivery of hepatitis b virus (hbv) vaccines |
CN118302524A (zh) | 2021-08-31 | 2024-07-05 | 纳诺索尔公司 | 高分子量修饰的dsRNA组合物 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443969A (en) | 1992-10-29 | 1995-08-22 | Rutgers University | RNA packaging system |
US6066318A (en) | 1995-10-05 | 2000-05-23 | G.D. Searle & Co. | Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors |
US6232287B1 (en) * | 1998-03-13 | 2001-05-15 | The Burnham Institute | Molecules that home to various selected organs or tissues |
GB9925459D0 (en) * | 1999-10-27 | 1999-12-29 | Plant Bioscience Ltd | Gene silencing |
GB9927444D0 (en) * | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression |
KR101215789B1 (ko) * | 2000-03-30 | 2012-12-26 | 화이트헤드 인스티튜트 포 바이오메디칼 리서치 | Rna 간섭의 rna 서열 특이적인 매개체 |
CH695778A5 (de) * | 2000-11-29 | 2006-08-31 | Hoffmann La Roche | Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben. |
US7320793B2 (en) | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
DE60233061D1 (de) | 2001-09-06 | 2009-09-03 | Alphavax Inc | Alphavirus replikon-vektorsysteme |
WO2003024481A2 (en) | 2001-09-14 | 2003-03-27 | Cytos Biotechnology Ag | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
IN2008CN05409A (pt) | 2002-07-18 | 2015-10-02 | Cytos Biotechnology Ag | |
WO2005001039A2 (en) * | 2003-05-29 | 2005-01-06 | Creighton University | Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof |
JP2007528727A (ja) * | 2004-02-27 | 2007-10-18 | ザ ダウ ケミカル カンパニー | 植物細胞における高効率ペプチド生産 |
GR20060100496A (el) * | 2006-09-01 | 2008-04-15 | Παρθενιος Μπουλικας | ΛΙΠΟΣΩΜΑΤΙΚΑ ΕΓΚΑΨΥΛΙΩΜΕΝΟΙ ΦΟΡΕΙΣ-ΥΒΡΙΔΙΟΥ ΑΔΕΝΟΙΟΥ - ΙΟΥ SEMLIKI FOREST (SFV), ΠΟΥ ΦΕΡΕΙ ΚΑΤΑΣΚΕΥΑΣΜΑΤΑ RNAi ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΑ ΓΟΝΙΔΙΑ ΠΟΥ ΧΡΗΣΙΜΟΠΟΙΟΥΝΤΑΙ ΕΝΑΝΤΙΟΝ ΣΤΟΧΩΝ ΚΑΡΚΙΝΟΥ ΚΑΙ ΑΛΛΩΝ ΑΣΘΕΝΕΙΩΝ |
US20080171361A1 (en) * | 2007-01-11 | 2008-07-17 | The Board Of Regents For Oklahoma State University | CAP-Independent Translational Enhancer for Protein Synthesis in Wheat Germ Extract and Transgenic Cereals |
CN101784655A (zh) | 2007-04-27 | 2010-07-21 | 菲尼克斯股份有限公司 | 可溶性重组二十面体病毒样颗粒的改良生成和体内装配 |
US20110111496A1 (en) * | 2007-06-29 | 2011-05-12 | Chiang Li | BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERY |
EP2085479A1 (en) | 2008-01-31 | 2009-08-05 | Institut Pasteur | Reverse genetics of negative-strand rna viruses in yeast |
US20110250675A1 (en) | 2008-03-26 | 2011-10-13 | Life Technologies Corporaiton | Virus-Like Particle Mediated Cellular Delivery |
US8324149B2 (en) | 2008-11-18 | 2012-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Encapsidation of heterologous entities into virus-like particles |
US8906863B2 (en) * | 2009-02-27 | 2014-12-09 | The Regents Of The University Of California | Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector |
US8906862B2 (en) | 2009-02-27 | 2014-12-09 | The Regents Of The University Of California | Multiple antigen delivery system using hepatitis E virus-like particle |
US20120174263A1 (en) * | 2009-06-15 | 2012-07-05 | Plant Bioscience Limited | Production of viral capsids |
US20130047297A1 (en) | 2010-03-08 | 2013-02-21 | Robert D. Sammons | Polynucleotide molecules for gene regulation in plants |
WO2011116226A2 (en) | 2010-03-17 | 2011-09-22 | Stc.Unm | Display of antibody fragments on virus-like particles of rna bacteriophages |
WO2012051152A2 (en) * | 2010-10-12 | 2012-04-19 | Kevin Ryan | Novel dna templates for small rna production in mammalian cells |
US20130224828A1 (en) * | 2010-11-01 | 2013-08-29 | Qapsule Technologies, Inc. | RNA-Directed Packaging of Enzymes Within Protein Particles |
JP2013018754A (ja) * | 2011-07-13 | 2013-01-31 | Univ Of Tokushima | 悪性胸膜中皮腫治療剤 |
WO2013065791A1 (ja) * | 2011-11-02 | 2013-05-10 | 公立大学法人大阪市立大学 | 遺伝子発現抑制用二本鎖核酸分子 |
AR089440A1 (es) | 2011-12-21 | 2014-08-20 | Apse Llc | Procesos que emplean particulas similares a virus (psv) con capsides resistentes a hidrolasas |
HUE053033T2 (hu) | 2013-06-19 | 2021-06-28 | Apse Llc | Hidrolázoknak ellenálló kapszidokat alkalmazó készítmények és eljárások |
US9932563B2 (en) * | 2013-09-11 | 2018-04-03 | Georgia Tech Research Corporation | Compositions and methods for inhibiting gene expressions |
-
2014
- 2014-06-05 HU HUE17170226A patent/HUE053033T2/hu unknown
- 2014-06-05 BR BR112015029559A patent/BR112015029559A2/pt not_active Application Discontinuation
- 2014-06-05 EP EP20202541.7A patent/EP3789017A1/en active Pending
- 2014-06-05 EP EP14813301.0A patent/EP3010494B1/en active Active
- 2014-06-05 EP EP17170226.9A patent/EP3222274B1/en active Active
- 2014-06-05 CA CA2912131A patent/CA2912131C/en active Active
- 2014-06-05 AU AU2014281061A patent/AU2014281061B2/en active Active
- 2014-06-05 US US14/897,577 patent/US9822361B2/en active Active
- 2014-06-05 SG SG11201510181YA patent/SG11201510181YA/en unknown
- 2014-06-05 ES ES17170226T patent/ES2847151T3/es active Active
- 2014-06-05 SG SG10201805197VA patent/SG10201805197VA/en unknown
- 2014-06-05 DK DK17170226.9T patent/DK3222274T3/da active
- 2014-06-05 PL PL17170226T patent/PL3222274T3/pl unknown
- 2014-06-05 WO PCT/US2014/041111 patent/WO2014204667A1/en active Application Filing
- 2014-06-05 JP JP2016521431A patent/JP6636418B2/ja active Active
- 2014-06-05 MX MX2015017593A patent/MX364809B/es active IP Right Grant
-
2015
- 2015-11-08 IL IL242487A patent/IL242487B/en active IP Right Grant
- 2015-12-17 MX MX2019005298A patent/MX2019005298A/es unknown
-
2017
- 2017-10-17 US US15/786,370 patent/US10428329B2/en active Active
-
2020
- 2020-12-04 CY CY20201101148T patent/CY1124583T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK3222274T3 (da) | 2020-11-02 |
EP3222274B1 (en) | 2020-10-21 |
CY1124583T1 (el) | 2022-03-24 |
CA2912131A1 (en) | 2014-12-24 |
EP3010494B1 (en) | 2018-08-15 |
SG10201805197VA (en) | 2018-07-30 |
WO2014204667A1 (en) | 2014-12-24 |
US9822361B2 (en) | 2017-11-21 |
EP3010494A4 (en) | 2017-06-07 |
MX2019005298A (es) | 2019-08-12 |
HUE053033T2 (hu) | 2021-06-28 |
SG11201510181YA (en) | 2016-01-28 |
MX364809B (es) | 2019-05-07 |
US20160177299A1 (en) | 2016-06-23 |
JP6636418B2 (ja) | 2020-01-29 |
US10428329B2 (en) | 2019-10-01 |
AU2014281061B2 (en) | 2019-07-18 |
IL242487B (en) | 2020-05-31 |
MX2015017593A (es) | 2016-04-15 |
AU2014281061A1 (en) | 2015-11-26 |
JP2016521992A (ja) | 2016-07-28 |
EP3010494A1 (en) | 2016-04-27 |
ES2847151T3 (es) | 2021-08-02 |
CA2912131C (en) | 2020-07-07 |
PL3222274T3 (pl) | 2021-07-19 |
EP3222274A1 (en) | 2017-09-27 |
US20180030445A1 (en) | 2018-02-01 |
EP3789017A1 (en) | 2021-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015029559A2 (pt) | partícula similar a vírus, ácido nucleico e métodos para produzir rna de fita dupla e sirna, shrna, sshrna, 1shrna e mirna | |
MX358762B (es) | Procesos que utilizan vlps con cápsides resistentes a hidrolasas. | |
WO2016061232A3 (en) | Multiplexed shrnas and uses thereof | |
SG194751A1 (en) | Compositions and methods for inhibiting gene expression of hepatitis b virus | |
MX2021000250A (es) | Secuencias 3 utr para estabilizacion de arn. | |
WO2014106837A3 (en) | ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST | |
CY1119491T1 (el) | Συνθεσεις και μεθοδοι για την αναστολη της εκφρασης του γονιδιου alas1 | |
MX2016007541A (es) | Moléculas modificadas de ácido nucleico y usos de las mismas. | |
BR112014009066B8 (pt) | molécula de ácido nucleico, método para a sintetização de uma molécula de dna de triciclo-fosforotioato e composição farmacêutica | |
WO2012024170A3 (en) | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | |
BR112015030491A8 (pt) | método de modular a expressão de um ácido nucleico alvo em uma célula, bem como método de alterar um ácido nucleico de dna alvo em uma célula | |
MX342927B (es) | Mimeticos sinteticos de mir-34. | |
SG195194A1 (en) | Nanogels | |
BR112015000710A8 (pt) | Oligonucleotídeos para fazer uma alteração na sequência de um presente alvo de molécula de rna em uma célula viva | |
MD20150006A2 (ro) | Inhibitori de micro-ARN din familia miR-15 | |
ZA202006505B (en) | Micro rna expression constructs and uses thereof | |
BR112018010499A2 (pt) | método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, população de células in vitro, método para produzir uma população de células, e população de células | |
WO2015048020A3 (en) | Compositions and methods for the manufacture of lipid nanoparticles | |
GB2496343A (en) | A method of treating attention deficit hyperactivity disorder | |
EA201690685A1 (ru) | Композиции и способы ингибирования экспрессии гена alas1 | |
NZ759538A (en) | Compositions and methods vectors for inducing an enhanced immune response using poxvirus vectors | |
Si et al. | Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activity | |
WO2015038915A3 (en) | Compositions and methods using capsids resistant to hydrolases | |
IN2014CN03921A (pt) | ||
BR112015022641A2 (pt) | construção de dna, célula hospedeira eucariótica, linhagem de células eucarióticas e processo de preparação de uma proteína-alvo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B25C | Requirement related to requested transfer of rights |
Owner name: APSE, LLC (US) Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 870230070475 DE 09/08/2023, E NECESSARIO APRESENTAR UMA GUIA DE RECOLHIMENTO, CODIGO 248, RELATIVA A ALTERACAO DE NOME OCORRIDA ANTES DA TRANSFERENCIA SOLICITADA. ALEM DISSO, E PRECISO APRESENTAR A GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: APSE, LLC (US) Free format text: ANULADA A PUBLICACAO CODIGO 25.3 NA RPI NO 2748 DE 05/09/2023 POR TER SIDO INDEVIDA. |
|
B25A | Requested transfer of rights approved |
Owner name: APSE, INC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: RNAISSANCE AG LLC (US) |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |